Ftse Mib
33.770,05
0,07%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.120,52
1,52%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Galectin Therapeutics Inc (GALT) Galectin Therapeutics Inc (GALT) Notizie

Galectin Therapeutics Inc

GALT
3,37
-0,13 (-3,71%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:34:36
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/3/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202322:15EDGAR2Form 8-K - Current report
07/12/202317:42EDGAR2Form 8-K - Current report
01/12/202322:50EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
01/12/202322:38EDGAR2Form SC 13D/A - General statement of acquisition of..
01/12/202314:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:21EDGAR2Form 8-K/A - Current report: [Amend]
13/11/202314:45GLOBEUPDATE – Galectin Therapeutics Reports Financial Results for..
13/11/202314:00GLOBEGalectin Therapeutics Reports Financial Results for the..
13/11/202313:55EDGAR2Form 8-K - Current report
13/11/202313:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202313:00GLOBEGalectin Therapeutics to Share Five Scientific Presentations..
31/10/202321:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202314:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
16/10/202314:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202314:00GLOBEGalectin Therapeutics Announces Nomination of Dr. Benjamin..
06/10/202314:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202314:03EDGAR2Form DEF 14A - Other definitive proxy statements
03/10/202314:00GLOBEGalectin Therapeutics Reports the Positive Outcome of the..
02/10/202313:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202320:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202314:00GLOBEGalectin Therapeutics to Present Update on its Belapectin..
18/9/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202322:38EDGAR2Form 144 - Report of proposed sale of securities
11/9/202314:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
07/9/202318:00GLOBEGalectin Therapeutics to Present Data on Liver Cirrhosis at..
01/9/202313:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202314:00GLOBEGalectin Therapeutics Reports Financial Results for the..
14/8/202313:55EDGAR2Form 8-K - Current report
14/8/202313:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202313:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202314:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202313:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 3,51 Min: 3,23 Max: 3,54
Chiusura: 3,50

La tua Cronologia

NASDAQ
GALT
Galectin Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network